Vinflunine Improves Response and Survival in Mesothelioma
NEW YORK NOV 08, 2007 (Reuters Health) - High-dose vinflunine, a novel microtubule inhibitor, provides encouraging response and survival rates in patients with malignant
pleural mesothelioma, according to a report in the October 20th issue of the Journal of Clinical Oncology.
Although numerous systemic
treatments have been evaluated malignant
pleural mesothelioma, the authors explain, response […]